During the past decade, Leland Stanford Junior University conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Leland Stanford Junior University" are "Aortic Aneurysm, Thoracic" (3 trials), "Aneurysm of Aortic Arch" (1 trials), "Aorta, Lesion" (1 trials), "Aorta; Lesion" (1 trials) and "Aortic Aneurysm, Abdominal" (1 trials). Many other conditions were trialed in "Leland Stanford Junior University" in a lesser frequency.

Most popular intervention types in "Leland Stanford Junior University" are "Device" (5 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "GORE® TAG® Thoracic Branch Endoprosthesis" (4 trials), "GORE® EXCLUDER® Conformable AAA Endoprosthesis" (1 trials), "Revascularization Procedure" (1 trials) and "belinostat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leland Stanford Junior University" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Leland Stanford Junior University". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Leland Stanford Junior University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Leland Stanford Junior University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".